Skip to main content
. 2024 Apr 11;14(4):e077582. doi: 10.1136/bmjopen-2023-077582

Figure 1.

Figure 1

Comparison of the characteristics of general practice patients and randomised trials patients (legends). Each subfigure displays the comparison of general practice patients to patients included in randomised trials. For the former, summary statistics (means and SD, or percentages) are reported on the right; for the former, a mean value (considered as a theoretical value) was obtained through meta-analyses of baseline characteristics of the patients included in the selected randomised trials. For each characteristic, a standardised difference between general practice and randomised patients was estimated and plotted. The dotted lines in −0.1 and 0.1 SD define the limits of a non-meaningful standardised difference. ACE inhibitor, angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor blockers; BMI, body mass index; BP, blood pressure; Hba1c, glycated haemoglobin; HDL-c, high-density lipoprotein cholesterol; LDL-c, low-density lipoprotein cholesterol.